Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-Β-dependent

Mucosal Immunology

Volumn 3, Issue 3, 2010, Pages 291-300

  Shirey, K A ^a   Pletneva, L M ^b   Puche, A C ^a   Keegan, A D ^a   Prince, G A ^b   Blanco, J C G ^b   Vogel, S N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Virion Systems Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; PARECOXIB; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAT6 PROTEIN; TOLL LIKE RECEPTOR 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; COTTON RAT; CYTOKINE PRODUCTION; DISEASE SEVERITY; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; LUNG INJURY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REINFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; WILD TYPE;

EID: 77951447568     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2010.6     Document Type: Article

References (47)

1. Welliver, R.C.Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.J. Pediatr. 143, S112 - 117 ( 2003 ). (Pubitemid 37456908)
2. Blanco, J.C.G., Boukhvalova, M., Pletneva, L., Prince, G.A.& Vogel, S.N.Re-thinking respiratory syncytial virus vaccines.Recent Res. Develop. Exp. Med. 1, 75-94.Appendix 1 ( 2004 ).
3. Boukhvalova, M.S., Prince, G.A., Soroush, L., Harrigan, D.C., Vogel, S.N.& Blanco, J.C.The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccineenhanced disease.Vaccine 24, 5027-5035 ( 2006 ). (Pubitemid 43782692)
4. Pletneva, L.M., Haller, O., Porter, D.D., Prince, G.A.& Blanco, J.C.Interferon-inducible Mx gene expression in cotton rats: cloning, characterization, and expression during influenza viral infection.J. Interferon Cytokine Res. 26, 914-921 ( 2006 ). (Pubitemid 46025681)
5. Kurt-Jones, E.A.et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.Nat. Immunol. 1, 398-401 ( 2000 ).
6. Murawski, M.R.et al. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.J. Virol. 83, 1492-1500 ( 2009 ).
7. Liu, P., Jamaluddin, M., Li, K., Garofalo, R.P., Casola, A.& Brasier, A.R.Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.J. Virol. 81, 1401-1411 ( 2007 ). (Pubitemid 46167861)
8. Haeberle, H.A.et al. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and Tolllike receptor 4-dependent pathways.J. Infect. Dis. 186, 1199-1206 ( 2002 ).
9. Bueno, S.M.et al. Host immunity during RSV pathogenesis.Int. Immunopharmocol. 8, 1320-1329 ( 2008 ).
10. Richardson, J.Y.et al. Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy.J. Immunol. 174, 4356-4364 ( 2005 ).
11. Pribul, P.K.et al. Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development.J. Virol. 82, 4441-4448 ( 2008 ).
12. Munder, M., Eichmann, K., Mor á n, J.M., Centeno, F., Soler, G.& Modelell, M.Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells.J. Immunol. 163, 3771-3777 ( 1999 ). (Pubitemid 29450901)
13. Gordon, S.Alternative activation of macrophages.Nat. Rev. Immunol. 3, 23-35 ( 2003 ). (Pubitemid 37328697)
14. Raes, G., No ë l, W., Beschin, A., Brys, L., De Baetselier, P.& Gholamreza Hassandsadeh, G.FIZZ1 and Ym as tools to discriminate between differentially activated macrophages.Develop. Immunol. 9, 151-159 ( 2002 ). (Pubitemid 36898373)
15. Shirey, K., Cole, L.E., Keegan, A.D.& Vogel, S.N.Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism.J. Immunol. 181, 4159-4167 ( 2008 ).
16. Kelly-Welch, A.E., Hanson, E.M., Boothby, M.R.& Keegan, A.D.Interleukin-4 and interleukin-13 signaling connection maps.Science 300, 1527-1528 ( 2003 ).
17. Stein, M., Keshav, S., Harris, N.& Gordon, S.IL-4 potently enhances murine macrophage mannose receptor activity; a marker for alternative immunologic macrophage activation.J. Exp. Med. 176, 287-292 ( 1992 ).
18. Welch, J.S., Escoubet-lozach, L., Sykes, D.B., Liddiard, K., Greaves, D.R.& Glass, C.K.T H 2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism.J. Biol. Chem. 277, 42821-42829 ( 2002 ). (Pubitemid 35285658)
19. Liu, T.et al. Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6.J. Immunol. 173, 3425-13421 ( 2004 ). (Pubitemid 39142053)
20. Haynes, L.M., Moore, D.D., Kurt-Jones, E.A., Finberg, R.W., Anderson, L.J.& Tripp, R.A.Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus.J. Virol. 75, 10730-10737 ( 2001 ).
21. Odegaard, J.I.et al. Macrophage-specific PPAR controls alternative activation and improves insulin resistance.Nature 447, 1116-1120 ( 2007 ).
22. Coste, A.et al. PPAR promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13.Immunity 19, 329-339 ( 2003 ). (Pubitemid 37153410)
23. Stienstra, R., Duval, C., Keshtkar, S., van der Laak, J., Kersten, S.& M ü ller, M.Peroxisome proliferator-activated receptor activation promotes infiltration of alternatively activated macrophages into adipose tissue.J Biol. Chem. 283, 22620-22627 ( 2008 ).
24. Prince, G.A., Jenson, A.B., Horswood, R.L., Camargo, E.& Chanock, R.M.The pathogenesis of respiratory syncytial virus infection in cotton rats.Am. J. Pathol. 93, 771-791 ( 1978 ). (Pubitemid 9087309)
25. Prince, G.A., Curtis, S.J., Yim, K.C.& Porter, D.D.Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.J. Gen. Virol. 82, 2881-2888 ( 2001 ).
26. Prince, G.A., Prieels, J.P., Slaoui, M.& Porter, D.D.Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccineenhanced disease in the cotton rat (Sigmodon hispidus).Lab. Invest. 79, 1385-1392 ( 1999 ).
27. McMurray, R.W.& Hardy, K.J.Cox-2 inhibitors: today and tomorrow.Am. J. Med. Sci. 323, 181-189 ( 2002 ).
28. Albina, J.E., Mills, C.D., Henry, W.L.Jr. & Caldwell, M.D.Temporal expression of different pathways of L-arginine metabolism in healing wounds.J. Immunol. 144, 3877-3880 ( 1990 ).
29. Kodelja, V., Muller, C., Tenorio, S., Schebesch, C., Orfanos, C.E.& Goerdt, S.Differences in angiogenic potential of classically vs alternatively activated macrophages.Immunobiology 197, 478-493 ( 1997 ). (Pubitemid 27489996)
30. Varin, A.& Gordon, S.Alternative activation of macrophages: immune function and cellular biology.Immunobiology 214, 630-1241 ( 2009 ).
31. Moore, M.L.et al. STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection.J. Immunol. 183:2016-2026 ( 2009 ).
32. El Kasmi, K.C.et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.Nat. Immunol. 9, 1399-1406 ( 2008 ).
33. Imai, Y.et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.Cell 133, 235-249 ( 2008 ). (Pubitemid 351512299)
34. Dubuquoy, L.et al. Impaired expression of peroxisome proliferatoractivated receptor in ulcerative colitis.Gastroenterology 124, 1265-1276 ( 2003 ). (Pubitemid 36531802)
35. Malur, A.et al. Deletion of PPAR in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response.J. Immunol. 182, 5816-5822 ( 2009 ).
36. Carey, M.A., Bradbury, J.A., Seubert, J.M., Langenbach, R., Zeldin, D.C.& Germolec, D.R.Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection.J. Immunol. 175, 6878-6884 ( 2005 ). (Pubitemid 41598933)
37. Didierlaurent, A.et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.J. Exp. Med. 205, 323-329 ( 2008 ). (Pubitemid 351281598)
38. Boukhvalova, M.S., Prince, G.A.& Blanco, J.C.Respiratory syncytial virus infects and abortively replicates in the lungs in spite of preexisting immunity.J. Virol. 81, 944-950 ( 2007 ).
39. Sigurs, N., Bjarnason, R., Sigurbergsson, F., Kjellman, B.& Bjorksten, B.Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.Pediatrics 95, 500-505 ( 1995 ).
40. Kim, E.Y.et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease.Nat. Med. 14, 633-640 ( 2008 ).
41. Anthony, R.M., Rutizky, L.I., Urban, J.F.Jr., Stadecker, M.J.& Gause, W.C.Protective immune mechanism in helminth infection.Nat. Rev. Immunol. 7, 975-987 ( 2007 ).
42. Chang, E.Y., Guo, B., Doyle, S.E.& Cheng, G.Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharideinduced IL-10 production.J. Immunol. 178, 6707-6709 ( 2007 ). (Pubitemid 46847391)
43. Prince, G.A., Mathews, A., Curtis, S.J.& Porter, D.D.Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model with systemically administered monoclonal antibody (Palivizumab) and glucocorticosteriod.J. Infect. Dis. 182, 1326-1330 ( 2000 ).
44. Cuesta, N., Salkowski, C.A., Thomas, K.E.& Vogel, S.N.Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-2.J. Immunol. 170, 5739-5747 ( 2003 ). (Pubitemid 36617867)
45. Cole, L.E.et al. Immunological consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.J. Immunol. 176, 6888-6899 ( 2006 ).
46. Blanco, J.C., Pletneva, L., Boukhvalova, M., Richardson, J.Y., Harris, K.A.& Prince, G.A.The cotton rat: an underutilized animal model for human infectious diseases can now be exploited using specific reagents to cytokine, chemokines and interferons.J. Interferon Cytokine Res. 24, 21-28 ( 2004 ). (Pubitemid 38147263)
47. Ford, A.Q., Smith, E., Noben-Trauth, N.& Keegan, A.D.Alternatively activated macrophages participate in the recruitment of eosinophils to the lung in a murine model of allergic lung inflammation.Suppl. J. Immunol. 182, 79-82 ( 2009 ).